Medication Use Over News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Message :
Required fields
SOUTH SAN FRANCISCO, Calif., May 16, 2021 (GLOBE NEWSWIRE) Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that new findings from analyses of claims data and electronic health records related to heart failure (HF) and hypertrophic cardiomyopathy (HCM) were shared in two poster presentations at the American College of Cardiology 70
th Annual Scientific Session & Expo (ACC.21). One poster presented data on spending for hospitalized Medicare patients with HF underscoring the economic burden of their healthcare, and an additional poster presented demographics and clinical characteristics of patients with hypertrophic cardiomyopathy.
“Together these analyses highlight the severity, complexity and burden associated with each of heart failure and hypertrophic cardiomyopathy as well as the high costs associated with managing the cycle of hospitalization and readmission for patients with heart failure,” said Robert I. Blum, Presid ....

United States , Roberti Blum , Diane Weiser , American College Of Cardiology , Healthcore Integrated Research Database , Exchange Commission , Cytokinetics Incorporated Nasdaq , Corporate Communications , Yale University School Of Medicine , American College , Annual Scientific Session , Chief Executive Officer , Spending Among Medicare Patients Hospitalized , Heart Failure , Substantial Payments , Post Acute Care , Yale University School , Cardiovascular Comorbidities , Medication Use Over , Medicare Advantage , Private Securities Litigation Reform Act , Safe Harbor , Vice President , Incorporated Stock Exchange , Press Release , Eart Cytk Us23282w6057 ,